While low-rely MBL hardly ever progresses to CLL, higher-depend MBL progresses to CLL demanding therapy in a rate of 1% to 2% per year. Higher-count MBL is distinguished from Rai 0 CLL determined by if the B-cell count is over or beneath 5 × 109/L. Despite the fact that men and women with equa